... 高的動力。 第二位的vivo次季度出貨量出現下滑,由於季內沒有旗艦新品發布,主要通過對X系列機型的補充;第三位 ...全文
... .1%。其中,華為、Vivo、OPPO、小米(01810)及蘋果公司分別排名出貨量前五。累計今年上半年,整體中 ...全文
... 率皆下滑,Oppo及Vivo出貨量分別按年挫18%及19%;小米出貨量按年勁跌20%,至1150萬部;蘋果手機 ...全文
... 別為華為、OPPO及vivo。三廠商的出貨總量佔智能手機市場的71.4%,其中華為的市場份額34.3%,銷量按 ...全文
... 's Honor, Vivo and Oppo. At the same time, it hopes to do well in the premium market. One of the main problems, however, is supply chain management. In late February, Xiaomi unveiled the Mi 9 flagship ...More
EJ Insight2019-07-11
... , Xiaomi, Vivo and Oppo, Samsung has seen its market share in the country fall to low single digits. Reduced to a bit player in the world's biggest smartphone market, after once being the top brand th ...More
EJ Insight2019-07-04
... com rival Vivo has also rapidly developed an impressive sports sponsorship portfolio. One suspects that Vivo’s title sponsorship of Indian Premier League cricket isn’t coincidental, and that it is int ...More
EJ Insight2019-06-28
... 小米(01810)及Vivo。然而,受到中美貿易談判僵局及需求減緩的影響,今年智能手機排名,三星仍坐穩第一,蘋 ...全文
工信部今日向中國電信、中國移動、中國聯通及中國廣電發放5G商用牌照。 手機廠商Vivo方面公布,其首款5G手機 ...全文
... rant、上海醫藥及Vivo Funds,合共認購全球發售股份約34.36%,涉及金額最多27.01億元。 與 ...全文
... 認購2500萬美元;Vivo Funds及上海醫藥投資各認購2000萬美元;股份禁售期6個月。 信誠證券聯席董 ...全文
... 認購2500萬美元;Vivo Funds及上海醫藥投資各認購2000萬美元。 該公司主要治療領域,包括中樞神經 ...全文
... 認購2500萬美元;Vivo Funds及上海醫藥投資各認購2000萬美元。 該公司計劃將集資所得用於研發項目 ...全文
Xiaomi was China's largest smartphone maker at one point in time in the past, establishing its presence before other domestic brands such as Oppo, Vivo and Huawei entered the market. But the company f ...More
EJ Insight2019-05-29
... Oppo and Vivo to grab some of the market share currently under Huawei's grip. Analysts will particularly keep an eye on Xiaomi, which has shown signs of flagging growth in recent months as it faced ...More
EJ Insight2019-05-22
... 《dinheiro vivo》報道,葡萄牙的應用商店Aptoide是谷歌內容商店最大的替代品牌之一,擁有超過9 ...全文